Answer
Galvus (vildagliptin) is not recommended for children and adolescents under 18 because its safety and efficacy have not been established and no data are available.
Sources for this answer
- Galvus 50 mg TabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 24Document updated
Sources checked